An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters for heart disease patients and what impact it has on the Indian heart ...
India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson's disease and severe heart failure, advancing ...
Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...
Morning Overview on MSN
Japan approves world-first iPSC therapy for Parkinson’s disease
Japan’s health ministry has endorsed the first stem-cell therapy derived from induced pluripotent stem cells (iPSCs) for ...
Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual | Drug Discovery And Development ...
Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.
Aspen Neuroscience, a clinical-stage regenerative medicine company developing autologous induced-pluripotent stem cell (iPSC) ...
A third "just in case" service to proactively store induced pluripotent stem (iPS) cells created with a client's blood for potential use if they develop future medical issues is s ...
US FDA clears Unixell Biotech’s IND for allogeneic iPSC-derived cell therapy, UX-GIP001 for focal epilepsy: Shanghai Monday, March 16, 2026, 17:00 Hrs [IST] Shanghai UniXell Bio ...
A pharmaceutical startup plans to begin a clinical trial in 2027 on a treatment for spinal cord injuries that uses nerve ...
This article describes an automated brain organoid creation workflow using the CellXpress.ai system, beginning with iPSCs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results